Conference abstractPublished 15 Jul 2013
Osteopontin splice variants are cancer progression markers
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
T he early detection of tumor dissemination is a challenge in cancer diagnosis because biomarkers for invasiveness are largely lacking in clinical medicine. Osteopontin is frequently secreted by cancer cells and plays important roles in their ability to metastasize. Despite a sizeable and continuously growing literature on osteopontin and cancer the molecule has not yet found entry into diagnostics. Osteopontin is subject to alternative splicing, which yields three messages, Osteopontin-a, -b, and -c. The shortest form, Osteopontin-c is selectively expressed in invasive, but not in non-invasive, breast tumor cell lines, and it effectively supports anchorage independence. Osteopontin-c is present in 75-80% of breast cancers and 0% of normal breast tissues. Our identification of Osteopontin variants that are more specific for cancer than the full-length transcript has opened new possibilities for measuring them in the blood as a means of early detection. We have developed a real- time RT-PCR blood test and evaluated it in a pilot study of breast, lung, pancreatic, gynecologic, and other cancers, compared to non-cancer controls. Osteopontin-b was increased in lung cancers and pancreatic cancers. When applying a cutoff of 2 standard deviations above normal, elevation in osteopontin-b transcripts detected over 40% of lung cancers. Osteopontin-c was increased in gynecologic and pancreatic cancers. Elevation in osteopontin-c also detected a fraction of breast cancers and lung cancers, suggesting heterogeneity within those types of tumors. Specifically, breast carcinomas were associated with significantly higher levels of osteopontin-c mRNA in the blood than carcinomas in situ . Osteopontin-b and -c in the blood are biomarkers for distinct cancers.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Biomarkers & Diagnosis
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Georg F. Weber”
